Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Randomized, Parallel, Double-blinding, 2-Arm Study to Investigate the Efficacy and Safety of Intra-articular ELIXCYTE (Adipose-Derived Stem Cells) Injection Compared With Placebo in Subjects With Knee Osteoarthritis

NCT05526001 is registered in ClinicalTrials.gov with UnicoCell Biomed CO. LTD as lead sponsor.

NCT NCT05526001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05526001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Randomized, Parallel, Double-blinding, 2-Arm Study to Investigate the Efficacy and Safety of Intra-articular ELIXCYTE (Adipose-Derived Stem Cells) Injection Compared With Placebo in Subjects With Knee Osteoarthritis
Lead sponsor
UnicoCell Biomed CO. LTD
Phase
Phase 3
Overall status
Active, not recruiting
Start date
July 3, 2023
Completion date
November 30, 2026
Enrollment
165 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis